Skip to content
Open access

Quantitative Evaluation of Freezing of Gait in Parkinson’s Disease Using Smartwatch Telemetry

Sep 2026 · Advances in Neurology and Neuroscience · Vol 09, pp. 01-09 · 0 citations

TL;DR

FOG Ratio derived from smartwatch telemetry is an exceptionally sensitive biomarker for capturing realworld day-to-day motor symptom swings, and environmental humidity modulates freezing severity, presenting new biometeorological insights for PD motor management.

Abstract

Background: Freezing of Gait (FOG) and daily motor fluctuations severely impair independence in Parkinson’s disease (PD). Continuous monitoring via consumer smartwatches offers a non-invasive way to measure real-world Digital Mobility Outcomes (DMOs). However, FOG-induced standstill and environmental variations cause measurement biases that are poorly characterized. Objective: To quantitatively evaluate Freezing of Gait (FOG) episodes in Parkinson’s disease using smartwatch telemetry, establish a simple and clinically intuitive Range Ratio metric (Mean ± Range Ratio %) to capture true day-to-day symptom variability without relying on standard deviation, assess FOG-induced GPS trajectory distance distortion, and investigate the potential moderating effects of ambient biometeorological factors (temperature and relative humidity) on gait motor performance. Methods: Field gait trials were conducted along an outdoor circuit (Fukuoka Park) ranging from 240 m to 800 m comparing Control sessions (n=4) and Test sessions exhibiting FOG (n=15). High-frequency time-series sensor data were recorded using the WorkOutDoors application on an Apple Watch Ultra 2 and analyzed via HealthFit and custom Excel processing pipelines. Day-to-day symptom variability across the 15 Test sessions was expressed using the Range Ratio (Mean±Range Ratio %), defined as [(Max−Min)/Mean]×100. Results: High-precision telemetry successfully extracted continuous spatiotemporal metrics. Test sessions exhibited significantly higher FOG Ratio (0.320 vs. 0.037, p = 2.26 × 10^-7) and massive GPS distance inflation (32.10% vs. 1.25%, p = 7.94 × 10^-8) compared to Controls. FOG Ratio showed strong inverse correlations with walking speed (r = -0.742) and step length (r = -0.685), confirming that spatial gait breakdown closely mirrors freezing severity. Across 15 test sessions, day-to-day symptom ranges expressed as Mean ± Range Ratio % were: FOG Ratio 0.32 ± 145.6%, Walking Speed 3.12 ± 55.8% km/h, Cadence 125.6 ± 39.9% spm, and Step Length 45.8 ± 27.1% cm. Ambient temperature showed no significant association with FOG Ratio (r = 0.188, p = 0.503) or GPS error (r = 0.284, p = 0.305). Conversely, relative humidity demonstrated a statistically significant inverse correlation with FOG Ratio (r = -0.594, p = 0.020) and GPS error ratio (r = -0.656, p = 0.008). Conclusion: FOG Ratio derived from smartwatch telemetry is an exceptionally sensitive biomarker for capturing realworld day-to-day motor symptom swings (145.6% fluctuation). GPS distance inflation during FOG motor arrest (~32%) mandates the integration of inertial zero-velocity filters in DMO algorithms. Environmental humidity modulates freezing severity, presenting new biometeorological insights for PD motor management.

Read PDF

Similar papers

Open access Oct 2026

Quantitative Classification of Parkinsonian Gait Disturbances Using Telemetry: Differentiating Akinetic Freezing and Inefficient Tremulous Gait

Background: We previously demonstrated that freezing of gait (FOG) in Parkinson’s disease (PD) can be objectively assessed using consumer smartwatch telemetry and that FOG episodes introduce significant spatial GPS distance distortion. However, parkinsonian gait impairment comprises distinct motor subtypes, notably com...

Zheng-Hua Li, K. Yamamura · 0 citations
Open access Oct 2026

Gait profile score as a summary index of gait pathology in freezing of gait and levodopa responses in Parkinson's disease.

BACKGROUND Freezing of gait (FoG) is a disabling manifestation of Parkinson's disease (PD). Most gait studies in FoG rely on spatiotemporal parameters or discrete kinematic peaks, which may underestimate multi-joint deviations across the gait cycle. The Gait Profile Score (GPS) and Gait Variable Score (GVS) were introd...

C. Fukuchi, Margarete de Jesus Carvalho, F. A. Barbieri et al. · 0 citations
Open access Nov 2026

Gait and balance features in Parkinson’s disease

Introduction: Parkinson’s disease (PD) is characterised by gait, balance, and cognitive impairments. These symptoms contribute to reduced mobility and increased risk of falls, substantially affecting the quality of life. Gait impairments are often reflected in increased step timing, greater gait variability, and postur...

Jenna Huxley, Charalampos Sotirakis, James J. Fitzgerald et al. · 0 citations
Open access Oct 2026

Wearable Inertial Phenotyping of Freezing of Gait in Parkinson’s Disease: Biomechanical Signatures, Subject-Independent Classification, and Clinical Associations

Wearable inertial signals showed clinically interpretable differences among FoG manifestations, while finer phenotype discrimination remained heterogeneous and requires external validation in independent cohorts.

A. Ielo, L. Bonanno, A. Quartarone et al. · 0 citations
Open access Nov 2026

Short intervals of inertial measurement unit data collected during activities of daily living can provide a quantitative method to assess disease severity and functional ability in Parkinson's disease

Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting roughly one million people in the U.S. People with PD (PwPD) exhibit classic motor symptoms that limit performance on functional tasks and reduce quality of life (QOL). Despite functional ability (FA) being a critical indicator of patient we...

V. Vanchinathan, M. Farah, A. Singh et al. · 0 citations
Open access Oct 2026

The FOG‐COA Protocol: Validation of Freezing of Gait Clinical Outcomes Assessments in Parkinson's Disease

The development and evaluation of novel treatment options for freezing of gait (FOG) in Parkinson's disease have been limited by an ambiguous definition and lack of standardized clinical outcome assessments (COAs) that 1) reliably assess FOG severity, 2) are responsive to change, and 3) capture patient‐relevant impact....

Erika E. Howe, Pieter Ginis, K. Ehgoetz Martens et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.